BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28035744)

  • 1. Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.
    Selfe J; Olmos D; Al-Saadi R; Thway K; Chisholm J; Kelsey A; Shipley J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram.
    De Salvo GL; Del Bianco P; Minard-Colin V; Chisholm J; Jenney M; Guillen G; Devalck C; Van Rijn R; Shipley J; Orbach D; Kelsey A; Rogers T; Guerin F; Scarzello G; Ferrari A; Cesen Mazic M; Merks JHM; Bisogno G;
    Cancer; 2024 Jul; 130(13):2351-2360. PubMed ID: 38400828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.
    Hingorani P; Missiaglia E; Shipley J; Anderson JR; Triche TJ; Delorenzi M; Gastier-Foster J; Wing M; Hawkins DS; Skapek SX
    Clin Cancer Res; 2015 Oct; 21(20):4733-9. PubMed ID: 26473193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.
    Dehner CA; Rudzinski ER; Davis JL
    Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9-Mediated Bioluminescent Tagging of Endogenous Proteins by Fluorescent Protein-Assisted Cell Sorting.
    Hawley RG; Hawley TS
    Methods Mol Biol; 2024; 2779():273-286. PubMed ID: 38526790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.
    Mosquera JM; Sboner A; Zhang L; Kitabayashi N; Chen CL; Sung YS; Wexler LH; LaQuaglia MP; Edelman M; Sreekantaiah C; Rubin MA; Antonescu CR
    Genes Chromosomes Cancer; 2013 Jun; 52(6):538-50. PubMed ID: 23463663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyosarcoma: current challenges and their implications for developing therapies.
    Hettmer S; Li Z; Billin AN; Barr FG; Cornelison DD; Ehrlich AR; Guttridge DC; Hayes-Jordan A; Helman LJ; Houghton PJ; Khan J; Langenau DM; Linardic CM; Pal R; Partridge TA; Pavlath GK; Rota R; Schäfer BW; Shipley J; Stillman B; Wexler LH; Wagers AJ; Keller C
    Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a025650. PubMed ID: 25368019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
    JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children's Oncology Group studies.
    Schloemer NJ; Xue W; Qumseya A; Luo LY; Hiniker SM; Lautz TB; Rhee DS; Arnold MA; Venkatramani R
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30701. PubMed ID: 37783659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Abbou S; Klega K; Tsuji J; Tanhaemami M; Hall D; Barkauskas DA; Krailo MD; Cibulskis C; Nag A; Thorner AR; Pollock S; Imamovic-Tuco A; Shern JF; DuBois SG; Venkatramani R; Hawkins DS; Crompton BD
    J Clin Oncol; 2023 May; 41(13):2382-2393. PubMed ID: 36724417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Chisholm J; Mandeville H; Adams M; Minard-Collin V; Rogers T; Kelsey A; Shipley J; van Rijn RR; de Vries I; van Ewijk R; de Keizer B; Gatz SA; Casanova M; Hjalgrim LL; Firth C; Wheatley K; Kearns P; Liu W; Kirkham A; Rees H; Bisogno G; Wasti A; Wakeling S; Heenen D; Tweddle DA; Merks JHM; Jenney M
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group.
    Martin-Giacalone BA; Richard MA; Scheurer ME; Khan J; Sok P; Shetty PB; Chanock SJ; Li SA; Yeager M; Marquez-Do DA; Barkauskas DA; Hall D; McEvoy MT; Brown AL; Sabo A; Scheet P; Huff CD; Skapek SX; Hawkins DS; Venkatramani R; Mirabello L; Lupo PJ
    J Natl Cancer Inst; 2023 Jun; 115(6):733-741. PubMed ID: 36951526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.
    Gallo-Oller G; Pons G; Sansa-Girona J; Navarro N; Zarzosa P; García-Gilabert L; Cabré-Fernandez P; Guillén Burrieza G; Valero-Arrese L; Segura MF; Lizcano JM; Sánchez de Toledo J; Moreno L; Gallego S; Roma J
    Exp Hematol Oncol; 2024 Apr; 13(1):38. PubMed ID: 38581035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of pediatric soft tissue tumors: clinical application.
    Chang CC; Shidham VB
    J Mol Diagn; 2003 Aug; 5(3):143-54. PubMed ID: 12876204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel THBS1::IGF1R fusion in myopericytic tumour.
    Kato K; Yamashita K; Dobashi A; Togashi Y; Baba S; Ae K; Matsumoto S; Takeuchi K
    Histopathology; 2024 Apr; ():. PubMed ID: 38576274
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of pretreatment circulating tumor DNA as a biomarker of poor outcome in intermediate-risk rhabdomyosarcoma.
    Navid F; Biegel JA
    Transl Pediatr; 2024 May; 13(5):869-872. PubMed ID: 38840688
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular diagnostics in the management of rhabdomyosarcoma.
    Arnold MA; Barr FG
    Expert Rev Mol Diagn; 2017 Feb; 17(2):189-194. PubMed ID: 28058850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.
    Becher OJ; Gilheeney SW; Khakoo Y; Lyden DC; Haque S; De Braganca KC; Kolesar JM; Huse JT; Modak S; Wexler LH; Kramer K; Spasojevic I; Dunkel IJ
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra.
    Chmielecki J; Bailey M; He J; Elvin J; Vergilio JA; Ramkissoon S; Suh J; Frampton GM; Sun JX; Morley S; Spritz D; Ali S; Gay L; Erlich RL; Ross JS; Buxhaku J; Davies H; Faso V; Germain A; Glanville B; Miller VA; Stephens PJ; Janeway KA; Maris JM; Meshinchi S; Pugh TJ; Shern JF; Lipson D
    Cancer Res; 2017 Jan; 77(2):509-519. PubMed ID: 28069802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to Treatment, Response and Patterns of Failure in Pediatric Parameningeal Rhabdomyosarcoma: Experience From a Tertiary Cancer Care Center From India.
    Roy S; Pathy S; Mohanti BK; Chander S; Biswas A
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e62-e68. PubMed ID: 28060113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.